Cancer Biology & Therapy
Volume 25, 2024 - Issue 1
Open access
3,293
Views
0
CrossRef citations to date
0
Altmetric
Research Paper
Diagnostic value of 18F-PSMA-1007 PET/CT for predicting the pathological grade of prostate cancer
Xiao-Bo Niua Department of Nuclear Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, People’s Republic of ChinaView further author information
, Yan-Peng Lia Department of Nuclear Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, People’s Republic of ChinaView further author information
, Jun Wangb Department of Urinary Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, People’s Republic of ChinaView further author information
, Xiao-Li Meia Department of Nuclear Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, People’s Republic of ChinaView further author information
, Xue-Yan Zhaoc Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, People’s Republic of ChinaView further author information
, Ting-Ting Liua Department of Nuclear Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, People’s Republic of ChinaView further author information
, Sha-Sha Xua Department of Nuclear Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, People’s Republic of ChinaView further author information
, Xing-Min Hana Department of Nuclear Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, People’s Republic of ChinaCorrespondence[email protected]
View further author information
& View further author information
Jing-Liang Chengd Department of Magnetic resonance, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, People’s Republic of ChinaCorrespondence[email protected]
https://orcid.org/0009-0002-2952-2278View further author information
Article: 2287120
|
Received 22 Aug 2023, Accepted 20 Nov 2023, Published online: 20 Dec 2023
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.